References
- Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–11.
- Ito S, Miranda WR, Nkomo VT, Connolly HM, Pislaru SV, et al. Reduced left ventricular ejection fraction in patients with aortic stenosis. J Am Coll Cardiol. 2018;71:1313–21.
- Shah SM, Shah J, Lakey SM, Garg P, Ripley DP. Pathophysiology, emerging techniques for the assessment and novel treatment of aortic stenosis. Open Heart. 2023;10:1–10.
- Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2022;43(7):561–632.
- Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5).
- Siontis GCM, Overtchouk P, Cahill TJ, Modine T, Prendergast B, Praz F, et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis. Eur Heart J. 2019;40(38):3143–53.
- Tarantini G, Delgado V, de Backer O, Sathananthan J, Treede H, Saia F, et al. Redo-transcatheter aortic valve implantation using the SAPIEN 3/Ultra transcatheter heart valves—expert consensus on procedural planning and techniques. Am J Cardiol. 2023;192:228–44.
- Petrescu I, Egbe AC, Ionescu F, Nkomo VT, Greason KL, Pislaru C, Pellikka PA, Connolly HM, Pislaru SV. Long-term outcomes of anticoagulation for bioprosthetic valve thrombosis. J Am Coll Cardiol. 2020;75:857–66.
- Makkar RR, Blanke P, Leipsic J, Thourani V, Chakravarty T, Brown D, et al. Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves: PARTNER 3 cardiac computed tomography substudy. J Am Coll Cardiol. 2020;75:3003–15.
- Blanke P, Leipsic JA, Popma JJ, Yakubov SJ, Deeb GM, Gada H, et al. Bioprosthetic aortic valve leaflet thickening in the Evolut low risk sub-study. J Am Coll Cardiol. 2020;75:2430–42.
- Kwiecinski J, Tzolos E, Cartlidge TRG, Fletcher A, Doris MK, et al. Native aortic valve disease progression and bioprosthetic valve degeneration in patients with transcatheter aortic valve implantation. Circulation. 2021;144:1396–408.
- Roth GA. Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990–2017. Circulation. 2020 May 26;141(21):1670–80.
- Goody PR, Hosen MR, Christmann D, Niepmann ST, Zietzer A, Adam M, et al. Aortic valve stenosis: from basic mechanisms to novel therapeutic targets. Arterioscler Thromb Vasc Biol. 2020;40:885–900.
- Spilias N, Martyn T, Denby KJ, Popovic ZB, Kapadia SR. Left ventricular systolic dysfunction in aortic stenosis: pathophysiology, diagnosis, management, and future directions. Struct Heart. 2022;6(5):100089.
- Khanji MY, Ricci F, Galusko V, Sekar B, Chahal CAA, Ceriello L, et al. Management of aortic stenosis: a systematic review of clinical practice guidelines and recommendations. Eur Heart J Qual Care Clin Outcomes. 2021;7(4):340–53.
- Boskovski MT, Gleason TG. Current therapeutic options in aortic stenosis. Circ Res. 2021;128(9):1398–417.
- Kalogeropoulos AS, Redwood SR, Allen CJ, Hurrell H, Chehab O, Rajani R, et al. A 20-year journey in transcatheter aortic valve implantation: evolution to current eminence. Front Cardiovasc Med. 2022;9:971762.
- Jørgensen TH, Gustav H, Thyregod H, Ihlemann N, Nissen H, Petursson P, et al. Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement. Eur Heart J. 2021;42(30):2912–9.
- Iung B, Pierard L, Magne J, Messika-Zeitoun D, Pibarot P, Baumgartner H. Great debate: all patients with asymptomatic severe aortic stenosis need valve replacement. Eur Heart J. 2023;44(33):3136–48.
- Fazzari F, Baggiano A, Fusini L, Ghulam Ali S, Gripari P, Junod D, et al. Early biological valve failure: structural valve degeneration, thrombosis, or endocarditis? J Clin Med. 2023 Sep 3;12(17):5740.
- Fauvel C, Capoulade R, Durand E, Béziau DM, Schott JJ, Le Tourneau T, Eltchaninoff H. Durability of transcatheter aortic valve implantation: a translational review. Arch Cardiovasc Dis. 2020;113(3):209–21.
- Blackman DJ, Saraf S, MacCarthy PA, Myat A, Anderson SG, Malkin CJ, et al. Long-term durability of transcatheter aortic valve prostheses. J Am Coll Cardiol. 2019;73(5):537–45.
- Linke A, Woitek F, Merx MW, Schiefer C, Möbius-Winkler S, Holzhey D, et al. Valve-in-valve implantation of Medtronic CoreValve prosthesis in patients with failing bioprosthetic aortic valves. Circ Cardiovasc Interv. 2012;5:689–97.
- Aurigemma C, Burzotta F, Vergallo R, Farina P, Romagnoli E, Cangemi S, et al. Transcatheter aortic valve implantation to treat degenerated surgical bioprosthesis: focus on the specific procedural challenges. Front Cardiovasc Med. 2022;9:895477.